← FDA Drug Approvals (Drugs@FDA)

NINTEDANIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMACEUTICALS DEVELOPMENT INC · Approved 2026-03-26

Drug application

FDA Application #

ANDA219371

Application type

Abbreviated New Drug Application (Generic)

Brand name

NINTEDANIB

Generic name

Nintedanib

Active ingredients

NINTEDANIB

Dosage form

CAPSULE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

TEVA PHARMACEUTICALS DEVELOPMENT INC

First approval

2026-03-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown